A critical discovery in cancer research is arising with the use of mini-antibodies to reactivate damaged p53. This vital malignant protector protein is frequently inactivated in many kinds of malignancies, causing https://bookmarklinx.com/story22009310/vhh-fragments-reactivate-p53-a-promising-approach-for-tumor-management